Michael S. Perry, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 4,000 shares at $76.09 ($304K) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Seasonal sale ($304k) by Director — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |